MedinCell S.A. (EPA:MEDCL)
26.22
+0.34 (1.31%)
Oct 22, 2026, 5:35 PM CEST
MedinCell Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, MedinCell stock has a consensus rating of "Strong Buy" and an average price target of €35.51. The average 1-year stock price forecast is 35.43% higher than the current stock price, while the lowest is €31.00 (+18.23%) and the highest is €41.00 (+56.37%).
Price Target: €35.51 (+35.43%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for MedinCell stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 9 | 9 | 9 | 9 | 8 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Kepler Capital | Kepler Capital | Hold Downgrades €31.00 | Hold | Downgrades | €31.00 | +18.23% | Oct 14, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains €29.40 | Buy | Maintains | €29.40 | +12.11% | Oct 13, 2026 |
| Oppenheimer | Oppenheimer | Buy Initiates €35.00 | Buy | Initiates | €35.00 | +33.49% | Sep 23, 2026 |
| Jefferies | Jefferies | Buy Maintains €38.00 | Buy | Maintains | €38.00 | +44.93% | Jun 24, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates €33.00 | Buy | Reiterates | €33.00 | +25.86% | May 22, 2026 |
Financial Forecast
Revenue This Year
38.94M
from 24.28M
Increased by 60.41%
Revenue Next Year
56.60M
from 38.94M
Increased by 45.35%
EPS This Year
0.03
from -0.94
EPS Next Year
0.52
from 0.03
Increased by 1,772.73%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.